1 / 45

강 창 현 서울대학교병원 흉부외과 서울대학교 의과대학

THE NEW LUNG CANCER STAGE CLASSIFICATION. 강 창 현 서울대학교병원 흉부외과 서울대학교 의과대학. Communication. Evaluation. Staging. Treatment. Prognosis. Research. TNM based stage. AJCC (1977). UICC (1958). Collaboration since 1982. AJCC Cancer Staging Manual editions. References.

buck
Télécharger la présentation

강 창 현 서울대학교병원 흉부외과 서울대학교 의과대학

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. THE NEW LUNG CANCER STAGE CLASSIFICATION 강 창 현 서울대학교병원 흉부외과 서울대학교 의과대학

  2. Communication Evaluation Staging Treatment Prognosis Research

  3. TNM based stage AJCC(1977) UICC(1958) Collaboration since 1982

  4. AJCC Cancer Staging Manual editions

  5. References • T-descriptors JTO 2007 • N-descriptors JTO 2007 • M-descriptors JTO 2007 • Stage grouping JTO 2007 • Validation JTO 2007

  6. References • SCLC (clinical staging) JTO 2007 • SCLC (pathological staging) JTO 2009 • Carcinoid tumors JTO 2008 • Additional prognostic factor JTO 2008 • IASLC nodal map JTO 2009

  7. AJCC 7th edition • Based on staging project by IASLC • International multi-institute data • Internal and external validation

  8. IASLC staging project

  9. IASLC database Time Frame 1990 ~ 2000 Source of data 45 sources from 20 countries

  10. Numbers of cases

  11. Treatment modalities Surgery+ Chemo4% Surgery+ RT5% Tri-modality3% Chemo+ RT12%

  12. Distribution by continent

  13. Validation Internal External By Data source Geographical regions By SEER data 1998-2000 Literature review

  14. Numbers analyzed • T descriptors 18,198 • N descriptors 28,371 • pN1 & pN2 2,876 • M descriptors 6,596 • SCLC (clinical) 8,088 • SCLC (Pathologic) 349 • Carcinoid tumor 513

  15. T-descriptors • Cutpoints of tumor size • Malignant pleural effusion • Separate nodules • Other T2 descriptors • Other T3 descriptors • Other T4 descriptors

  16. New cutpoints in size

  17. T1 learning set (n=2,284) T2 learning set (n=2607)

  18. Separate nodules & Malignant effusion

  19. N-descriptors • Verification of N1, N2, & N3 • Location of involved LNs • Number of involved LN stations • Skip metastasis • Anatomical “zones”

  20. Negative results • Peripheral specific LNs • Single specific LN zones • Presence of skip metastasisdid not had prognostic significance(except LUL with AP zone single metastasis)

  21. Positive results? • N1a single N1 zone • N1b Multiple N1 zone • N2a Single N2 zone • N2b Multiple N2 zone

  22. Overall disease burden, rather than anatomical location may have the most important influence on outcome

  23. Suggestions • Six Nodal zones • Subdivision to 3 prognostic groups • N1a • N1b & N2a • N2b • No change of current N-descriptors

  24. Discrepancy in nodal maps MD-ATS map(Mountain-Dresler modification of American Thoracic Society map) Naruke map(Japan Lung Cancer Society map) vs.

  25. M-descriptors • Separate nodules • Same lobe • Same lung • Contralateral lung • Malignant pleural effusion • Distant metastasis • Site of interest (brain) • Single vs. multiple

  26. Stage grouping

  27. AJCC the 6th edition

  28. AJCC the 7th edition

  29. Small cell lung cancer

  30. Carcinoid tumor

  31. Potential prognostic factors • Tumor characteristics • Patients characteristics • Laboratory parameters • Tumor biology

  32. Potential prognostic factors

  33. Changes in the 7th edition • Recommended for the classification of both NSCLC and SCLC and for carcinoid tumors • T classification • T1a (≤2cm) and T1b (>2-3cm) • T2a (>3-5cm) and T2b (>5-7cm) • T2 (>7cm) → T3 • Multiple tumor nodules in the same lobe → T3 • Multiple tumor nodules in the same lung → T4

  34. Changes in the 7th edition • No changes in N classification • But new international nodal map was proposed • M classification • Malignant pleural or pericardial effusion → M1a • Separate tumor nodules in contralateral lung → M1a • M1b designates distant metastasis • MX designation has been eliminated

  35. Limitations • Lack of detailed data in each descriptors • Too small numbers in specific category • Different lymph node maps • Biased distribution in treatment modality • Effect of treatment had not been considered

  36. New IASLC Prospective project • Prospective data acquisition • International multi-institute study • Complete set of data • Including non-anatomical prognostic factors

  37. Timetable • 2009-2010 Data collection • 2011-2012 Follow-up • 2013 Data analysis • Jan 2014 Submission of recommendations to UICC and AJCC • Jan – July 2014 Publication in JTO • 2016 Publication of 8th edition of TNM classification by the UICC and AJCC

  38. Future

More Related